X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3533) 3533
oncology (2873) 2873
female (1940) 1940
male (1810) 1810
chemotherapy (1757) 1757
adult (1565) 1565
middle aged (1515) 1515
high-dose chemotherapy (1410) 1410
antineoplastic combined chemotherapy protocols - therapeutic use (1277) 1277
cancer (1267) 1267
aged (1017) 1017
cisplatin (995) 995
treatment outcome (937) 937
hematology (891) 891
cisplatin - administration & dosage (675) 675
combined modality therapy (670) 670
adolescent (664) 664
prognosis (627) 627
high-dose cisplatin (601) 601
transplantation (597) 597
care and treatment (590) 590
antineoplastic combined chemotherapy protocols - adverse effects (516) 516
antineoplastic agents - adverse effects (490) 490
antineoplastic agents - therapeutic use (487) 487
pharmacology & pharmacy (486) 486
medicine & public health (470) 470
retrospective studies (461) 461
therapy (450) 450
disease-free survival (448) 448
child (440) 440
etoposide (434) 434
antineoplastic combined chemotherapy protocols - administration & dosage (417) 417
high-dose methotrexate (415) 415
phase-ii trial (409) 409
survival rate (405) 405
survival analysis (390) 390
transplantation, autologous (388) 388
radiotherapy (386) 386
double-blind (372) 372
cisplatin - adverse effects (371) 371
salvage therapy (366) 366
bone-marrow-transplantation (364) 364
neoplasm staging (364) 364
phase-ii (358) 358
hematopoietic stem cell transplantation (347) 347
survival (341) 341
animals (339) 339
etoposide - administration & dosage (337) 337
health aspects (323) 323
research (323) 323
stem cells (322) 322
high-dose metoclopramide (316) 316
cyclophosphamide (314) 314
follow-up studies (314) 314
vomiting - chemically induced (310) 310
carboplatin (309) 309
combination chemotherapy (294) 294
child, preschool (293) 293
tumors (292) 292
drug administration schedule (286) 286
hematology, oncology and palliative medicine (285) 285
dose-response relationship, drug (283) 283
trial (283) 283
surgery (282) 282
risk factors (280) 280
neoplasms - drug therapy (276) 276
bone-marrow transplantation (275) 275
high-dose therapy (272) 272
randomized-trial (272) 272
stem-cell transplantation (272) 272
pediatrics (271) 271
antineoplastic agents - administration & dosage (270) 270
young adult (266) 266
carcinoma (264) 264
vomiting - prevention & control (264) 264
toxicity (259) 259
cyclophosphamide - administration & dosage (255) 255
colony-stimulating factor (254) 254
immunology (254) 254
randomized trial (253) 253
nausea - chemically induced (250) 250
non-hodgkins-lymphoma (250) 250
prevention (248) 248
antiemetics - therapeutic use (247) 247
analysis (245) 245
ifosfamide (245) 245
clinical trials as topic (243) 243
doxorubicin (241) 241
dexamethasone (240) 240
nausea (234) 234
children (220) 220
prognostic-factors (219) 219
time factors (215) 215
prospective studies (211) 211
recurrence (211) 211
adjuvant chemotherapy (209) 209
cisplatin - therapeutic use (209) 209
stem cell transplantation (208) 208
nausea - prevention & control (207) 207
lymphomas (206) 206
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4406) 4406
German (64) 64
French (59) 59
Japanese (33) 33
Spanish (6) 6
Korean (5) 5
Chinese (4) 4
Italian (4) 4
Polish (3) 3
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of nephrology, ISSN 1724-6059, 2017, Volume 31, Issue 1, pp. 15 - 25
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2009, Volume 10, Issue 11, pp. 1063 - 1069
Summary Background The best chemotherapy regimen for metastatic gastric cancer is uncertain, but promising findings have been reported with irinotecan plus cisplatin and S-1... 
Hematology, Oncology and Palliative Medicine | SUPPORTIVE CARE | 5-FLUOROURACIL | LEUCOVORIN | ONCOLOGY | HIGH-DOSE METHOTREXATE | DOXORUBICIN | MITOMYCIN | EUROPEAN-ORGANIZATION | 1ST-LINE THERAPY | III TRIAL | CHEMOTHERAPY | Japan - epidemiology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - secondary | Cisplatin - administration & dosage | Young Adult | Fluorouracil - therapeutic use | Fluorouracil - adverse effects | Time Factors | Adult | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Drug Administration Schedule | Risk Assessment | Administration, Oral | Tegafur - adverse effects | Tegafur - therapeutic use | Proportional Hazards Models | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Oxonic Acid - adverse effects | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Oxonic Acid - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Infusions, Intravenous | Stomach Neoplasms - mortality | Drug Combinations | Adenocarcinoma - mortality | Chemotherapy | Oncology, Experimental | Information services | Research | Metastasis | Stomach cancer | Information services industry | Cancer | Fluorouracil | Index Medicus
Journal Article
British journal of pharmacology, ISSN 0007-1188, 2014, Volume 171, Issue 11, pp. 2888 - 2899
Journal Article